Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: China Clear all

278 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20077
20082
20093
20103
20118
201211
20139
20149
201513
201610
201715
20189
201913
202020
202129
202220
202323
202434
202522
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status127
Recruiting60
Completed44
Not yet recruiting22
Active, not recruiting11
Terminated10
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University24
Peking University13
Chinese Academy of Medical Sciences11
Sun Yat-sen University11
The First Affiliated Hospital with Nanjing Medical University11
Tianjin Medical University Cancer Institute and Hospital10
Nanfang Hospital, Southern Medical University8
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology7
AstraZeneca6
Chinese PLA General Hospital6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms278
Esophageal Neoplasms9
Neoplasm Metastasis9
Colorectal Neoplasms8
Adenocarcinoma6
Biliary Tract Neoplasms4
Breast Neoplasms4
Endometrial Neoplasms4
Pancreatic Neoplasms4
Colonic Neoplasms3

Trials

Showing 1 to 25 of 278. Each trial links to its page on Pharma Observatory.

178 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.